Indeed, bendamustine is consistently associated with prolonged lymphopenia, especially CD4 + depletion, delayed immune recovery (median 7–9 months), and a higher incidence of opportunistic infections (PJP, VZV, CMV) (Fung et al. 2019; Saito et al. 2015). Here, CD4 is linked to pneumocystosis.